ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992

Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.

September 28, 2001

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

Court Agreement Clears The Way For Human Gene Transplant Study

May 26, 1989

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013